In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NIH Sequester: Grants Down, But SBIR Program Less Impacted

This article was originally published in The Gray Sheet

Executive Summary

Each institute within NIH has taken a slightly different approach to responding to the sequestration cuts, and, generally, the Small Business Innovation Research and Small Business Technology Transfer grant programs are subject to less significant reductions than traditional grants.

You may also be interested in...



Final Coverage-With-Evidence-Development Guidance Delayed By CMS Staff Cuts

The CMS coverage and analysis group has had to divert its attention from finishing a CED guidance to finalizing proposed changes to the process for awarding Medicare coverage for IDE trials, primarily due to staff cuts, says Louis Jacques, who heads the group.

Human Genome Research Led To $65 Billion In Economic Output In 2012, Says Battelle Report

A Battelle report on the impact of genomics on the U.S. economy found that research on human genome sequencing led to $65 billion in economic output in 2012, and contributed $31 billion toward the 2012 gross domestic product.

Human Genome Research Led To $65 Billion In Economic Output In 2012, Says Battelle Report

A Battelle report on the impact of genomics on the U.S. economy found that research on human genome sequencing led to $65 billion in economic output in 2012, and contributed $31 billion toward the 2012 gross domestic product.

Related Content

Topics

UsernamePublicRestriction

Register

ID1131437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel